4,8-dicarboxyl-8,9-iridoid-1-glycoside Promotes Neural Stem Cell Differentiation Through MeCP2.

Area of Science:

• Neuroscience
• Stem Cell Biology
• Pharmacology

Background:

• Borojó (Borojoa patinoi Cuatrec) fruit exhibits potential health benefits, but underlying mechanisms require investigation.
• Embryonic neural stem cells (NSCs) are crucial for neural development and repair.
• Understanding compounds that influence NSC behavior is vital for regenerative medicine.

Purpose of the Study:

• To investigate the effect of 4,8-dicarboxyl-8,9-iridoid-1-glycoside (388), a compound from Borojó, on embryonic NSC proliferation and differentiation.
• To elucidate the role of MeCP2 in the observed effects of 388 on NSCs.

Main Methods:

• Neural stem cells (NSCs) were cultured and treated with varying doses of 388.
• Cell viability, proliferation, and differentiation were assessed.
• Western blotting and immunofluorescence staining were used to evaluate NSC differentiation markers and MeCP2 expression.
• MeCP2 knockdown experiments were performed to confirm its role.

Main Results:

• Compound 388 did not affect NSC viability during proliferation.
• Treatment with 388 significantly enhanced neural differentiation in both cortical and spinal cord-derived NSCs upon mitogen withdrawal.
• 388 treatment led to a significant upregulation of MeCP2 expression.
• Knockdown of MeCP2 abolished the pro-differentiation effect of 388, indicating its crucial role.

Conclusions:

• Compound 388 from Borojó stimulates the differentiation of embryonic neural stem cells.
• The pro-differentiation effect of 388 is mediated through the upregulation of MeCP2.
• This finding provides mechanistic insight into the potential neuroprotective benefits of Borojó.